CD40LG and rheumatoid arthritis: Evaluating EBV serological data of all RA patients during the defined time interval, we found a significant reduction in seroprevalence for anti-VCA IgM and anti-EA(D) IgM after 6 months (p = 0.004 and p = 0.031, respectively) (Table 2).